New Veterinary Anesthesia and Analgesia
A veterinary publication highlights recent products and protocols for anesthesia and pain management, including a new drug, monitoring devices, and a pain
A recent article in Veterinary Practice News outlines several new and updated products, protocols, and procedures for veterinary anesthesia and analgesia. The report, aimed at veterinary professionals, covers innovations in drug delivery, patient monitoring, and pain assessment.
New Drug and Delivery System
A new non-steroidal anti-inflammatory drug (NSAID) called cimicoxib is now available for dogs. According to the source, it is administered as an oral paste. The article states that this formulation offers an alternative method for providing post-operative pain relief.
Alongside new pharmaceuticals, the report discusses an advanced drug delivery device. The Syrvet SX2 syringe driver is highlighted. This device allows for the continuous, precise infusion of medications like lidocaine or ketamine. The source describes it as a tool for providing constant-rate infusions during surgical procedures.
Monitoring and Assessment Tools
The article also reviews new monitoring equipment. The DigiPette E electronic pipette is mentioned as a device for accurately measuring and delivering small volumes of anesthetic drugs. This aims to improve dosing precision.
For pain assessment, the source describes the Glasgow Composite Measure Pain Scale-Feline (CMPS-Feline). This is a tool to help veterinarians objectively evaluate pain levels in cats. The report presents it as an aid for making more informed decisions about analgesia.
The following table compares the key products and tools mentioned in the source article:
Updated Protocols and Considerations
Beyond hardware and pharmaceuticals, the source article touches on revised procedural guidelines. It mentions that the American College of Veterinary Anesthesia and Analgesia (ACVAA) has updated its recommendations for monitoring anesthetized patients. These new guidelines emphasize the importance of continuous monitoring for parameters like blood pressure and oxygenation.
The report also includes a cautionary note on a specific drug combination. It advises against mixing dexmedetomidine and ketamine in the same syringe. The source states this mixture can form a precipitate, potentially compromising the drug's efficacy and safety.
Finally, the article briefly discusses the use of lidocaine constant-rate infusions for managing pain in horses. This is presented as an established technique that continues to be relevant in equine practice. The source provides this overview without endorsing any specific product over another.
